Benjamin Hohl

Insider Reports History

Entity
Individual
Location
6200 Lookout Road, Boulder, CO
Signature
/s/ Benjamin Hohl
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Benjamin Hohl:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Enliven Therapeutics, Inc. CHIEF FINANCIAL OFFICER Common Stock 0 $0 $25.38 Nov 27, 2024 Direct
Enliven Therapeutics, Inc. CHIEF FINANCIAL OFFICER Stock Option (right to buy) 169K Nov 27, 2024 Direct

Insider Reports Filed by Benjamin Hohl

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELVN Enliven Therapeutics, Inc. Nov 27, 2024 4 -$118K 4 Dec 2, 2024 CHIEF FINANCIAL OFFICER
ELVN Enliven Therapeutics, Inc. Oct 28, 2024 4 -$163K 4 Oct 30, 2024 CHIEF FINANCIAL OFFICER
ELVN Enliven Therapeutics, Inc. Oct 18, 2024 3 -$22.4K 4 Oct 22, 2024 CHIEF FINANCIAL OFFICER
ELVN Enliven Therapeutics, Inc. Oct 4, 2024 6 -$288K 4 Oct 8, 2024 CHIEF FINANCIAL OFFICER
ELVN Enliven Therapeutics, Inc. Oct 1, 2024 3 -$13.1K 4 Oct 3, 2024 CHIEF FINANCIAL OFFICER
ELVN Enliven Therapeutics, Inc. Sep 27, 2024 6 -$138K 4 Oct 1, 2024 CHIEF FINANCIAL OFFICER
ELVN Enliven Therapeutics, Inc. Aug 27, 2024 3 -$85.2K 4 Aug 29, 2024 CHIEF FINANCIAL OFFICER
ELVN Enliven Therapeutics, Inc. Jul 31, 2024 3 -$24.8K 4 Aug 2, 2024 CHIEF FINANCIAL OFFICER
ELVN Enliven Therapeutics, Inc. Jul 29, 2024 4 -$127K 4 Jul 31, 2024 CHIEF FINANCIAL OFFICER
ELVN Enliven Therapeutics, Inc. Jul 12, 2024 3 -$67.8K 4 Jul 16, 2024 CHIEF FINANCIAL OFFICER
ELVN Enliven Therapeutics, Inc. Jun 27, 2024 5 -$85.4K 4 Jul 1, 2024 CHIEF FINANCIAL OFFICER
ELVN Enliven Therapeutics, Inc. May 28, 2024 5 -$88K 4 May 30, 2024 CHIEF FINANCIAL OFFICER
ELVN Enliven Therapeutics, Inc. May 3, 2024 3 -$20K 4 May 7, 2024 CHIEF FINANCIAL OFFICER
ELVN Enliven Therapeutics, Inc. Apr 29, 2024 3 -$47.1K 4 May 1, 2024 CHIEF FINANCIAL OFFICER
ELVN Enliven Therapeutics, Inc. Apr 11, 2024 4 -$311K 4 Apr 15, 2024 CHIEF FINANCIAL OFFICER
ELVN Enliven Therapeutics, Inc. Mar 27, 2024 4 -$51.2K 4 Mar 29, 2024 CHIEF FINANCIAL OFFICER
ELVN Enliven Therapeutics, Inc. Feb 27, 2024 3 -$47.1K 4 Feb 29, 2024 CHIEF FINANCIAL OFFICER
ELVN Enliven Therapeutics, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 CHIEF FINANCIAL OFFICER
ELVN Enliven Therapeutics, Inc. Jan 29, 2024 3 -$43.3K 4 Jan 31, 2024 CHIEF FINANCIAL OFFICER
ELVN Enliven Therapeutics, Inc. Dec 28, 2023 9 -$149K 4 Jan 2, 2024 Chief Financial Officer
ELVN Enliven Therapeutics, Inc. Dec 22, 2023 6 -$14.2K 4 Dec 27, 2023 Chief Financial Officer
ELVN Enliven Therapeutics, Inc. Apr 4, 2023 1 $0 4 Apr 6, 2023 Chief Financial Officer
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 1 $0 4 Feb 27, 2023 Chief Financial Officer
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 0 $0 3 Feb 27, 2023 Chief Financial Officer